ORGO Organogenesis Holdings Inc.

Overview and Growth

In fiscal 2025, Organogenesis Holdings Inc. recorded $564.17M of revenue, net income of $37.03M, and an operating cash outflow of $10.31M. The $564.17M revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Compared with $482.04M in fiscal 2024, revenue recorded a 17.0% year-over-year increase. The company reported diluted EPS of $0.15, adding a shareholder-level measure to the absolute income figures considered below. Total assets stood at $598.73M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Revenue equaled 0.94x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Operating income was $44.69M, the earnings remaining from reported operations after the company’s recognized operating cost structure. Operating margin measured 7.9%, showing the portion of revenue preserved after the full set of operating costs. The bottom-line result was net income of $37.03M, after the operating, financing, tax, and other items recognized for the period. Net margin was 6.6%, meaning that this portion of revenue remained as net income after all recognized expenses. EBITDA was $59.97M, adding a pre-interest, tax, depreciation, and amortization view of the company’s earnings capacity. The earnings statement records $46.97M of pretax income, the profit base against which the reported tax provision can be assessed. Pretax income represented 8.3% of revenue, placing earnings before tax in the context of the company’s operating scale. The company recognized $9.94M of income tax for the period, completing the transition from pretax income to net income. The income-tax provision equaled 21.2% of pretax income, showing the tax burden absorbed by the year’s earnings. Return on period-end equity was 12.3%, relating annual net income to the equity capital on the balance sheet. Return on period-end assets was 6.2%, connecting net income with the company’s total asset base. Current net income of $37.03M was above fiscal 2024 net income of $861.00K, showing the direction of the bottom-line change.

Liquidity and Capital Structure

At period end, current assets of $362.19M compared with current liabilities of $100.12M, defining the company’s short-term resource position. At 3.62x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $93.68M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 93.6% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Equity equaled 50.1% of assets, showing the shareholder-capital layer within the company’s balance sheet. Liabilities represented 27.5% of total assets, quantifying the liability-funded share of the company’s resource base. Measured against total assets, cash and equivalents represented 15.6%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $497.89M in fiscal 2024, the current asset base moved 20.3% and finished higher. Book equity was 14.2% higher than fiscal 2024 equity of $262.90M, showing how shareholder capital changed year over year. Cash and equivalents were 30.9% lower than fiscal 2024 cash of $135.57M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities used $10.31M of cash, resulting in an operating cash outflow for the year. Capital spending of $14.15M added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. Negative free cash flow was $24.46M, leaving a cash deficit after capital spending and reducing financial flexibility. The free-cash-flow deficit equaled 4.3% of revenue, showing the post-investment cash shortfall relative to sales. The cash deficit after capital spending represented 4.1% of the period-end asset base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Sep 24, 2026.